| Mouse ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment E Maniati, C Berlato, G Gopinathan, O Heath, P Kotantaki, A Lakhani, ... Cell reports 30 (2), 525-540. e7, 2020 | 71 | 2020 |
| Targeting versican as a potential immunotherapeutic strategy in the treatment of cancer P Hirani, V Gauthier, CE Allen, TN Wight, OMT Pearce Frontiers in Oncology 11, 712807, 2021 | 22 | 2021 |
| Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis EH Puttock, EJ Tyler, M Manni, E Maniati, C Butterworth, M Burger Ramos, ... Nature Communications 14 (1), 2514, 2023 | 15 | 2023 |
| Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate P Hirani, J McDermott, V Rajeeve, PR Cutillas, JL Jones, DJ Pennington, ... Cancer Research Communications 4 (4), 970-985, 2024 | | 2024 |
| Investigating the role of versican in immune exclusion in triple negative breast cancer P Hirani | | 2024 |
| Exploring the role of versican in immune exclusion within triple negative breast cancer P Hirani, KM Alonge, DJ Pennington, PR Cutillas, TN Wight, OM Pearce Cancer Research 83 (7_Supplement), 5841-5841, 2023 | | 2023 |
| Extracellular matrix educates a tumor macrophage phenotype found in ovarian cancer metastasis EH Puttock, EJ Tyler, M Manni, E Maniati, C Butterworth, E Peerani, ... bioRxiv, 2022.08. 11.503568, 2022 | | 2022 |
